Navigation Links
CTDC Announces the Disposal of Non-core Business
Date:12/20/2007

-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Act of 1934. These statements relate to future events or the Company's future financial performance. The Company has attempted to identify forward-looking statements by terminology including "anticipates", "believes", "expects", "can", "continue", "could", "estimates", "expects", "intends", "may", "plans", "potential", "predict", "should", or "will" or the negative of these terms or other comparable terminology. These statements are only predictions, uncertainties and other factors may cause the Company's actual results, level of activity, performance or achievements to be materially different from any future results, level of activity, performance or achievements expressed or implied by these forward-looking statements. The information in this Report on Form 6-K is not intended to project future performance of the Company. Although the Company believes that the expectations reflected in the forward- looking statements are reasonable, the Company does not guarantee future results, level of activity, performance or achievements. The Company's expectations are as of the date this Form 6-K is filed, and the Company does not intend to update any of the forward-looking statements after the date this Report on Form 6-K is filed to conform these statements to actual results, unless required by law.

Enquiries:

Stephan Yao

General Manager, PR/IR Department

Tel: +852-3112-8461

Email: ir@chinactdc.com


'/>"/>
SOURCE China Technology Development Group Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , BOSTON and COPENHAGEN, Nov. 30 /PRNewswire/...unced today that the Harvard Medical School ICCB-L...nized as a MicroRNA Screening Center of Excellence...l School, and associated hospitals and institution... and RNAi libraries. ,, MicroRNAs are a novel c...
(Date:11/30/2009)... , LONDON, November 30 /PRNewswire/...mpany, was named Europe,s fastest growing,Biotech/...y in the Deloitte,2009 Technology Fast 500 for EME...s annual ranking is based on a companies, five-yea... rate of 8,318% over this period. This,achievement...
(Date:11/29/2009)... release is available in German . , The con... modern physics. The most famous example is that o...eutrons. Now Prof. Bella Lake from Helmholtz-Zentr...cientists report for the first time an experimenta...n observed in a condensed matter system. , The c...
(Date:11/27/2009)... , DURHAM, N.C., Nov. 27 C...l initiate water-soluble carbon nanotube-based can...water-soluble carbon nanotubes, which have functio...n with cancer drugs, was developed in partnership ...jugated carbon nanotubes serves as a drug delivery...
Breaking Biology Technology:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Spinons -- confined like quarks 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2
... Key words: adenoviral vector • viral tra...l; gene delivery, , There is a req...ate lead candidate drugs arising from primary scre...ological assays. There is also a need in early-sta... as modulate the activity of, a plethora of molecu...
... M. Kenrick, S. Hancock, S. Stubbs, and N. Thoma...rdiff, UK , , Recent advances in s...oughput image analysis platforms such as the IN Ce...lysis of genes and proteins. Here, we describe the...reen fluorescent protein (GFP) ◊ cell cycle se...
...nd H.C. Birnboim , DNA Genotek Inc., Ott...ed with Oragene works well with TaqMan SNP Genotyp...thetase and apolipoprotein E genes were reliably ,...tion , Single-nucleotide polymorphisms ... to occur at 1 out of every 1,000 bases in t...
Other Biology Technology:Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 2Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 3Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 4Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 5Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 6Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 7Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 8Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 9Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 10siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 2siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 3siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 4siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 5siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 6siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 7Oragene is compatible with TaqMan SNP genotyping 2Oragene is compatible with TaqMan SNP genotyping 3
(Date:11/26/2009)...st worked out a way of using recordings of birdson...ns. This is the first time sound recordings from a...te estimates of bird species, populations. Because...ical Society,s Journal of Applied Ecology , will ...r advance in our ability to monitor whale and dolp...
(Date:11/26/2009)...istant Staphylococcus Aureus ) and other drug-res...perature plasma prototype devices have been develo...ricidal cocktails. , Two prototype devices have ...healthy skin (e.g. hands and feet) in hospitals an...hreat; and another to shoot bacteria-killing agent...
(Date:11/25/2009)...fighters, police officers and ambulance workers fa...Center complex. They battled to save people from t... tackled fires and evacuated as many people as the...,000 people. And making their jobs even harder was...rkers and their relatives jammed mobile networks w...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Longer Hormone Treatment May Improve Prostate Cancer Outlook 48526 1Longer Hormone Treatment May Improve Prostate Cancer Outlook 48526 2Longer Hormone Treatment May Improve Prostate Cancer Outlook 48526 3Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 1Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 2Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 3San Francisco Symposium Provides Training for Communities Looking to Develop Arts Programs That Unite Generations 48519 1San Francisco Symposium Provides Training for Communities Looking to Develop Arts Programs That Unite Generations 48519 2San Francisco Symposium Provides Training for Communities Looking to Develop Arts Programs That Unite Generations 48519 3
... Like a 1950,s Detroit automaker, it appears that ...d, sturdy chassis. , A new study combining advanc...ents by molecular biologists at Rice University an...t stable parts of a protein are also the parts tha... 13 issue of the journal Structure. , Nature ref...
... Researchers have found that a class of RNA molecu...n fact protect sex cells from self-destructing. Th...issue of the journal Cell. , Central to this disc...n. When a gene is ready to produce a protein, the ... The first strand produces a molecule called messe...
... New research offers tantalizing clues as to why s...ecome more aggressive or kill themselves. The res...science, which is published by the American Psycho...e University of Texas at Austin found that juvenil...ride, which is sold in the United States as Prozac...
Other Biology News:Protein folding: Building a strong foundation 2Scientists discover role for dueling RNAs 2Adolescent but not adult hamsters are more aggressive on low dose of fluoxetine 2
NK Cell Chip-IHC from 3H Biomedical AB
UCB PDC Cell Chip-IHC from 3H Biomedical AB
Guanosine 5′-O-(2-Thiodiphosphate), Trilithium Salt from Calbiochem
Suramin, Sodium Salt from Calbiochem
Biology Products: